Related Experiment Videos
Comparison of four techniques for detection of antibodies to cytomegalovirus
Y J Kraat1, R M Hendrix, M P Landini
1Department of Medical Microbiology, University of Limburg, Academic Hospital Maastricht, The Netherlands.
Insights
This study compared four methods for detecting cytomegalovirus (CMV) antibodies in donors. Microparticle enzyme immunoassay showed favorable results for screening CMV infections in blood and organ donors.
Area of Science:
- Virology
- Immunology
- Clinical Diagnostics
Background:
- Cytomegalovirus (CMV) is a common virus with significant implications for organ transplantation and blood transfusions.
- Accurate serological detection of CMV antibodies is crucial for donor screening to prevent transmission.
- Evaluating new diagnostic assays is essential for improving screening efficiency and accuracy.
Purpose of the Study:
- To compare the performance of four distinct serological assays for detecting cytomegalovirus (CMV) antibodies.
- To evaluate the suitability of these methods for routine screening of blood and organ donors.
- To identify the most effective assay for identifying previous CMV infections in donor populations.
Main Methods:
- Comparison of four serological methods: Western blotting (immunoblotting), latex agglutination, enzyme-linked immunosorbent assay (ELISA), and microparticle enzyme immunoassay (MEIA).
- Evaluation of assay performance in detecting cytomegalovirus antibody.
- Application of assays to blood and organ donor samples.
Main Results:
- The microparticle enzyme immunoassay (MEIA) demonstrated comparable performance to established methods.
- MEIA showed favorable results when compared against Western blotting, latex agglutination, and ELISA.
- The study identified MEIA as a potentially effective tool for CMV antibody screening.
Conclusions:
- Microparticle enzyme immunoassay (MEIA) is a viable and effective method for screening blood and organ donors for cytomegalovirus (CMV) infection.
- MEIA offers a promising alternative for CMV antibody detection, potentially improving donor screening protocols.
- Further validation may confirm MEIA's role in ensuring the safety of blood and organ donations.
Abstract:
Four serological methods were compared and evaluated for use in detecting cytomegalovirus antibody in blood and organ donors. Western blotting (immunoblotting), latex agglutination, enzyme-linked immunosorbent assay, and a recent available microparticle enzyme immunosorbent assay were used. The microparticle enzyme immunoassay appears to compare favorably with each of the other three assays tested for screening blood and organ donors for a previous cytomegalovirus infection.